Milestone Pharmaceuticals(MIST) - 2019 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) Table of Contents The aggregate market value (approximate) of the registrant's common equity held by non-affiliates based on the closing price of a share of the registrant's common share for The Nasdaq Stock Market on June 30, 2019 (the last business day of the registrant's most recently completed second fiscal quarter) was $217.5 million. As of March 3, 2020, the total number of shares outstanding of the registrant ...